Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-11 Purchase | 2021-08-13 06:58 am | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & General Counsel | 430 | $46.28 | $19,900 | 430 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Exercise | 2024-02-15 4:05 pm | N/A 2028-06-13 | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & GENERAL COUNSEL | 24,166 | $0 | 25,924 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:05 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & GENERAL COUNSEL | 20,000 | $2.78 | 25,924 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:05 pm | N/A N/A | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & GENERAL COUNSEL | 4,166 | $9.0165 | 25,924 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:17 pm | 2024-06-15 2033-06-15 | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & GENERAL COUNSEL | 74,000 | $0 | 74,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:18 pm | 2023-06-16 2032-06-16 | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & GENERAL COUNSEL | 73,000 | $0 | 73,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:29 pm | 2022-06-17 2031-06-17 | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & General Counsel | 73,000 | $0 | 73,000 (Direct) | View |
Ownership | 2021-01-04 08:10 am | N/A 2026-03-01 | Celldex Therapeutics Inc. | CLDX | Jimenez Freddy A. SVP & General Counsel | 0 | $0 | 64,231 (Direct) | View |